These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7890653)

  • 41. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
    Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
    Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product.
    Mulligan-Kehoe MJ; Wagner R; Wieland C; Powell R
    J Biol Chem; 2001 Mar; 276(11):8588-96. PubMed ID: 11113116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immobilization of the distal hinge in the labile serpin plasminogen activator inhibitor 1: identification of a transition state with distinct conformational and functional properties.
    De Taeye B; Compernolle G; Dewilde M; Biesemans W; Declerck PJ
    J Biol Chem; 2003 Jun; 278(26):23899-905. PubMed ID: 12686544
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms.
    Hansen M; Busse MN; Andreasen PA
    Eur J Biochem; 2001 Dec; 268(23):6274-83. PubMed ID: 11733024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate, and cleaved forms.
    Sancho E; Declerck PJ; Price NC; Kelly SM; Booth NA
    Biochemistry; 1995 Jan; 34(3):1064-9. PubMed ID: 7827021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator.
    van Meijer M; Roelofs Y; Neels J; Horrevoets AJ; van Zonneveld AJ; Pannekoek H
    J Biol Chem; 1996 Mar; 271(13):7423-8. PubMed ID: 8631768
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of plasminogen activator inhibitor type-1 (PAI-1) with vitronectin.
    Arroyo De Prada N; Schroeck F; Sinner EK; Muehlenweg B; Twellmeyer J; Sperl S; Wilhelm OG; Schmitt M; Magdolen V
    Eur J Biochem; 2002 Jan; 269(1):184-92. PubMed ID: 11784312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S; Larsen JV; Pedersen KE; Petersen HH; Egelund R; Christensen A; Jensen JK; Gliemann J; Andreasen PA
    FEBS J; 2006 Nov; 273(22):5143-59. PubMed ID: 17042782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1.
    Rezaie AR
    Biochemistry; 1998 Sep; 37(38):13138-42. PubMed ID: 9748320
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of a two-domain binding site for the urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex in low-density-lipoprotein-receptor-related protein.
    Andersen OM; Petersen HH; Jacobsen C; Moestrup SK; Etzerodt M; Andreasen PA; Thøgersen HC
    Biochem J; 2001 Jul; 357(Pt 1):289-96. PubMed ID: 11415462
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutational and immunochemical analysis of plasminogen activator inhibitor 1.
    Shubeita HE; Cottey TL; Franke AE; Gerard RD
    J Biol Chem; 1990 Oct; 265(30):18379-85. PubMed ID: 2120233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombin-variable region 1 (VR1). Evidence for the dominant contribution of VR1 of serine proteases to their interaction with plasminogen activator inhibitor 1.
    Horrevoets AJ; Tans G; Smilde AE; van Zonneveld AJ; Pannekoek H
    J Biol Chem; 1993 Jan; 268(2):779-82. PubMed ID: 8419354
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enthalpy measurement using calorimetry shows a significant difference in potential energy between the active and latent conformations of PAI-1.
    Sherman WA; Blouse GE; Perron MJ; Tran T; Shore JD; Gafni A
    Biol Chem; 2005 Feb; 386(2):111-6. PubMed ID: 15843154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants.
    Lawrence DA; Strandberg L; Ericson J; Ny T
    J Biol Chem; 1990 Nov; 265(33):20293-301. PubMed ID: 1700786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequence requirements in the reactive-center loop of plasminogen-activator inhibitor-1 for recognition of plasminogen activators.
    Tucker HM; Gerard RD
    Eur J Biochem; 1996 Apr; 237(1):180-7. PubMed ID: 8620872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasminogen activator inhibitor-1 polymers, induced by inactivating amphipathic organochemical ligands.
    Pedersen KE; Einholm AP; Christensen A; Schack L; Wind T; Kenney JM; Andreasen PA
    Biochem J; 2003 Jun; 372(Pt 3):747-55. PubMed ID: 12656676
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Single fluorescence probes along the reactive center loop reveal site-specific changes during the latency transition of PAI-1.
    Qureshi T; Peterson CB
    Protein Sci; 2016 Feb; 25(2):487-98. PubMed ID: 26540464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural similarity of the covalent complexes formed between the serpin plasminogen activator inhibitor-1 and the arginine-specific proteinases trypsin, LMW u-PA, HMW u-PA, and t-PA: use of site-specific fluorescent probes of local environment.
    Backovic M; Stratikos E; Lawrence DA; Gettins PG
    Protein Sci; 2002 May; 11(5):1182-91. PubMed ID: 11967374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RNA aptamers as conformational probes and regulatory agents for plasminogen activator inhibitor-1.
    Madsen JB; Dupont DM; Andersen TB; Nielsen AF; Sang L; Brix DM; Jensen JK; Broos T; Hendrickx ML; Christensen A; Kjems J; Andreasen PA
    Biochemistry; 2010 May; 49(19):4103-15. PubMed ID: 20387790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variants of tissue-type plasminogen activator that display extraordinary resistance to inhibition by the serpin plasminogen activator inhibitor type 1.
    Tachias K; Madison EL
    J Biol Chem; 1997 Jun; 272(23):14580-5. PubMed ID: 9169416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.